Diabetic cognitive decline is an increasingly recognized complication of both type 1 and type 2 diabetes, affecting up to 60% of individuals with the condition. It manifests as deficits in memory, executive function, processing speed, and attention—symptoms that can erode quality of life and independence long before more severe neurodegenerative diseases like Alzheimer's appear. While strict glycemic control remains the cornerstone of prevention, emerging research points to natural compounds that may offer neuroprotective benefits alongside conventional treatments. Among these, Lion’s Mane mushroom (Hericium erinaceus) has attracted significant scientific interest for its potential to improve cognitive function and even reverse some of the damage caused by chronic hyperglycemia.

Understanding Diabetic Cognitive Decline

Diabetic cognitive impairment is not a single disorder but a spectrum of cognitive changes driven by multiple pathological mechanisms. Chronic high blood glucose leads to the accumulation of advanced glycation end-products (AGEs), which damage neurons and blood vessels in the brain. Insulin resistance, a hallmark of type 2 diabetes, also impairs brain insulin signaling—a system crucial for synaptic plasticity, memory formation, and neuronal survival. Additionally, diabetes fuels a state of low-grade systemic inflammation that crosses the blood-brain barrier, activating microglia and promoting neuroinflammation. Oxidative stress, resulting from mitochondrial dysfunction and excess reactive oxygen species (ROS), further accelerates neuronal injury. Over time, these processes contribute to brain atrophy, particularly in the hippocampus and prefrontal cortex—regions vital for learning and executive function.

While the risk is highest in individuals with poorly controlled diabetes, even those with well-managed glucose levels can experience subtle cognitive decline. This suggests that factors beyond glucose—such as insulin resistance, lipid metabolism, and vascular health—play independent roles. Identifying interventions that address these broader pathways is therefore a priority for researchers.

The Unique Properties of Lion’s Mane Mushroom

Lion’s Mane is a tooth fungus native to North America, Europe, and Asia, long prized in traditional Chinese and Japanese medicine for its ability to nourish the nervous system and strengthen the digestive tract. Its common name comes from its cascading, icicle-like spines that resemble a lion’s mane. Modern pharmacology has isolated several bioactive compounds responsible for its health effects:

  • Hericenones – small molecules that can cross the blood-brain barrier and stimulate nerve growth factor (NGF) synthesis in the brain.
  • Erinacines – diterpenoid compounds that are even more potent NGF inducers, acting on astrocytes to boost NGF production.
  • Beta-glucans – polysaccharides with immunomodulatory and antioxidant properties that reduce systemic inflammation.
  • Other phenolic compounds and sterols that contribute to neuroprotection and anti-inflammatory activity.

Unlike many medicinal mushrooms that require hot water extraction to release beta-glucans, Lion’s Mane benefits are best obtained from dual-extraction (water and alcohol) to capture both water-soluble polysaccharides and alcohol-soluble hericenones and erinacines. This dual approach maximizes the range of bioactive compounds available for cognitive support.

How Lion’s Mane May Counteract Diabetic Cognitive Decline

The mechanisms by which Lion’s Mane could mitigate diabetes-related cognitive decline are multifaceted and align well with the underlying pathology. Below are the primary pathways supported by current evidence.

Stimulating Nerve Growth Factor (NGF)

NGF is a protein essential for the survival, maintenance, and regeneration of neurons, particularly cholinergic neurons in the basal forebrain—a population severely affected in cognitive decline and Alzheimer’s disease. In diabetic individuals, NGF levels are often reduced in the hippocampus and cortex, contributing to synaptic loss and impaired plasticity. Both hericenones and erinacines have been shown to upregulate NGF production in cultured astrocytes and in animal models. A 2016 study found that oral administration of Lion’s Mane extract increased NGF mRNA expression in the hippocampus of mice with streptozotocin-induced diabetes, correlating with improved performance in the Morris water maze test. This suggests that Lion’s Mane can directly counteract one of the key neurotrophic deficits seen in diabetic encephalopathy.

Reducing Neuroinflammation

Chronic hyperglycemia activates the NLRP3 inflammasome in microglia, the brain’s immune cells, leading to excessive release of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. This neuroinflammatory environment damages neurons and impairs synaptic function. Lion’s Mane has demonstrated potent anti-inflammatory effects in several animal studies. Erinacines suppress microglial activation and reduce cytokine production by inhibiting NF-κB and MAPK signaling pathways. In a 2020 rodent model of type 2 diabetes with cognitive impairment, treatment with Lion’s Mane extract significantly lowered hippocampal levels of IL-6 and TNF-α while preserving cognitive function in novel object recognition and Barnes maze tasks. By dampening neuroinflammation, Lion’s Mane may protect against the synaptic loss and white matter damage characteristic of diabetic cognitive decline.

Antioxidant Effects

Oxidative stress is a major driver of neuronal death in diabetes. High glucose increases ROS production through mitochondrial dysfunction, glucose autoxidation, and activation of the polyol pathway. Lion’s Mane is rich in phenolic antioxidants that scavenge free radicals and upregulate endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase. In a 2018 study on diabetic rats, Lion’s Mane supplementation restored SOD and catalase activity in brain tissue while reducing malondialdehyde (MDA), a marker of lipid peroxidation. This antioxidant defense helps preserve mitochondrial integrity and prevent apoptosis in neurons, particularly in the hippocampus.

One area of particular interest is Lion’s Mane’s ability to chelate transition metals like iron and copper, which become dysregulated in diabetes and contribute to ROS generation. By sequestering these metals, the mushroom may offer an additional layer of protection against oxidative damage.

Improving Insulin Signaling in the Brain

Brain insulin resistance is increasingly recognized as a core feature of diabetic cognitive decline and a risk factor for Alzheimer’s disease. When neurons lose sensitivity to insulin, they cannot efficiently take up glucose, leading to energy deficits and synaptic dysfunction. Moreover, insulin normally promotes synaptic plasticity and long-term potentiation, processes essential for memory. Lion’s Mane may enhance brain insulin sensitivity through several mechanisms. Its beta-glucans have been shown to improve systemic insulin sensitivity in diabetic mice, likely via modulation of gut microbiota and reduction of inflammatory signals. Additionally, hericenones have been found to upregulate insulin receptor expression in hippocampal neurons in vitro. In a 2021 study on high-fat diet-induced cognitive impairment, Lion’s Mane extract improved glucose tolerance and restored insulin signaling markers (pAkt, IRS-1) in the brain, leading to improved spatial memory. If these findings translate to humans, Lion’s Mane could help restore the energy metabolism and plasticity that diabetic brains lose.

Review of Current Scientific Evidence

Most of the evidence supporting Lion’s Mane for diabetic cognitive decline comes from preclinical studies, but a small number of human trials have examined its effects on cognitive function in other populations (e.g., older adults with mild cognitive impairment). Here is a summary of key findings:

  • Animal studies: At least a dozen independent rodent models of diabetes (both type 1 and type 2) have shown that Lion’s Mane extract (typically 200–500 mg/kg daily for 4–8 weeks) improves performance on memory tasks (Morris water maze, Y-maze, novel object recognition) while reducing markers of neuroinflammation, oxidative stress, and neuronal apoptosis. Some studies also report increased NGF levels and hippocampal neurogenesis.
  • Human trials in non-diabetic populations: A 2009 double-blind, placebo-controlled trial in Japanese adults aged 50–80 with mild cognitive impairment found that 3 g of Lion’s Mane powder daily for 16 weeks significantly improved scores on the Revised Hasegawa Dementia Scale (HDS-R) compared to placebo. Benefits disappeared after supplementation ceased, suggesting a reversible effect. A 2020 systematic review of four randomized controlled trials concluded that Lion’s Mane may improve cognitive function in older adults, though quality varied.
  • Direct diabetic cognitive decline data: As of 2025, there are no published human trials specifically examining Lion’s Mane in diabetic individuals with cognitive impairment. However, a 2023 pilot study (preprint) evaluated a standardized extract in 30 adults with type 2 diabetes and subjective cognitive complaints, reporting improvements in processing speed and working memory after 12 weeks. Full peer-reviewed results are awaited.

While the animal evidence is robust, the human evidence remains preliminary. The lack of direct clinical trials in diabetic populations is a significant gap that researchers are actively addressing. Several registered clinical trials are currently recruiting participants to evaluate Lion’s Mane for cognitive outcomes in type 2 diabetes.

Practical Considerations: Dosage, Safety, and Interactions

For individuals with diabetes considering Lion’s Mane supplementation, safety and dosing are critical considerations. The mushroom has an excellent safety profile with few reported side effects—most commonly mild gastrointestinal upset or allergic reactions in sensitive individuals. No serious adverse events have been documented in clinical trials using up to 5 g daily for extended periods.

Typical dosages used in research range from:

  • 1–3 g of dried fruiting body powder per day (taken in capsules or as a culinary ingredient).
  • 500–1000 mg of standardized extract (dual-extracted, containing both hericenones and erinacines).

It is important to purchase Lion’s Mane from reputable sources that provide third-party testing for purity and potency, as the market is largely unregulated. Look for products that specify the percentage of beta-glucans or hericenones.

Potential interactions: Lion’s Mane may have mild blood sugar-lowering effects based on animal studies. People taking diabetes medications (especially insulin or sulfonylureas) should monitor glucose levels closely when starting supplementation to prevent hypoglycemia. Additionally, because Lion’s Mane affects blood clotting (it has mild antiplatelet activity), individuals on anticoagulants like warfarin should consult their healthcare provider before use. The mushroom is also known to stimulate NGF, which theoretically could affect cancer cell growth—though no evidence indicates harm, those with active cancers should exercise caution and discuss with an oncologist.

Consult a healthcare provider before adding Lion’s Mane to your regimen, especially if you have diabetes, take prescription medications, or have underlying health conditions. This information is for educational purposes and does not replace medical advice.

Future Research Directions

The next few years promise to clarify Lion’s Mane’s role in diabetic cognitive decline. Researchers are focusing on several key questions:

  • Optimal dosage and formulation: Determining the most effective combination of hericenones and erinacines, and whether whole mushroom powder or standardized extracts are superior.
  • Long-term safety and efficacy: Controlled trials lasting 12 months or more to assess whether benefits persist and if any long-term risks emerge.
  • Synergy with conventional diabetes treatments: Whether Lion’s Mane enhances the cognitive benefits of metformin, GLP-1 agonists, or SGLT2 inhibitors.
  • Biomarker validation: Measuring brain NGF levels, inflammatory markers, and brain insulin sensitivity in human participants to confirm mechanisms.
  • Impact on dementia risk: Longitudinal studies examining whether Lion’s Mane supplementation reduces the incidence of Alzheimer’s or vascular dementia in diabetic populations.

Additionally, researchers are exploring the gut-brain axis, as Lion’s Mane has prebiotic effects that may alter gut microbiota composition in ways that reduce systemic inflammation and improve brain function—an area ripe for investigation in the context of diabetes.

Conclusion

Lion’s Mane mushroom stands out as one of the most promising natural supplements for supporting brain health in the face of diabetes-related cognitive decline. Its ability to stimulate nerve growth factor, reduce neuroinflammation, provide antioxidant protection, and improve brain insulin signaling directly addresses the pathological hallmarks of diabetic encephalopathy. Preclinical evidence is compelling, and early human research in non-diabetic older adults supports its cognitive benefits. However, the lack of dedicated human trials in diabetic populations means that definitive recommendations cannot yet be made.

For individuals with diabetes who are concerned about cognitive health, Lion’s Mane represents a low-risk, potentially beneficial adjunct to standard diabetes management—provided it is used under medical supervision. As research accelerates, we may soon have the evidence needed to make Lion’s Mane a standard recommendation in the comprehensive care of diabetes. Until then, maintaining tight glycemic control, engaging in regular physical and mental activity, eating a nutrient-dense diet, and managing cardiovascular risk factors remain the proven foundation for preserving cognitive function. Lion’s Mane may one day join that foundation, offering a natural, side-effect-free tool to protect the brain that diabetes too often compromises.

For further reading, explore the National Institutes of Health Office of Dietary Supplements fact sheet on cognitive supplements, the PubMed database of Lion’s Mane and cognition studies, and the Alzheimer’s Forum therapeutic database for updates on clinical trials.